Ghaith Aljayyoussi

Boehringer Ingelheim (Germany) — Germany

Medicine · Health Sciences

23h-index1.7kcitations66works5.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(12), Parasitic Diseases Research and Treatment(12), Mosquito-borne diseases and control(10), Tuberculosis Research and Epidemiology(8), SARS-CoV-2 and COVID-19 Research(7)

Publications66 total

Comparison of the analytical and clinical sensitivities of 34 rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UK
Microbiology Spectrum·2025Open Access
<i>Anopheles</i> mosquito survival and pharmacokinetic modeling show the mosquitocidal activity of nitisinone
Science Translational Medicine·2025· 9 citedOpen Access
Head-to-head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UK
BMJ Open Respiratory Research·2025· 2 citedOpen Access
Predicting Pharmacokinetics in Rats Using Machine Learning: A Comparative Study Between Empirical, Compartmental, and <scp>PBPK</scp> ‐Based Approaches
Clinical and Translational Science·2025· 5 citedOpen Access
<i>In silico</i> PK predictions in Drug Discovery: Benchmarking of Strategies to Integrate Machine Learning with Empiric and Mechanistic PK modelling
2024· 4 citedOpen Access
Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice
Frontiers in Immunology·2024· 13 citedOpen Access
Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis
Frontiers in Microbiology·2024· 6 citedOpen Access
Comparison of the analytical and clinical sensitivity of thirty-four rapid antigen tests with prevalent SARS-CoV-2 variants of concern during the COVID-19 pandemic in the UK
2023· 5 citedOpen Access
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro
Pharmaceuticals·2023· 18 citedOpen Access
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome <i>bd</i> and Chemical Validation of Combination Strategies for Respiratory Inhibitors against <i>Mycobacterium tuberculosis</i>
ACS Infectious Diseases·2023· 26 citedOpen Access
Head-to head comparison of anterior nares and nasopharyngeal swabs for SARS-CoV-2 antigen detection in a community drive-through test centre in the UK
2022· 6 citedOpen Access
The aerobiology of SARS-CoV-2 in UK hospitals and the impact of aerosol generating procedures
2022· 2 citedOpen Access
Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
International Journal of Antimicrobial Agents·2022· 23 citedOpen Access
SARS-CoV-2 viability on sports equipment is limited, and dependent on material composition
Scientific Reports·2022· 13 citedOpen Access
SARS-CoV-2 Transmission Risk from sports Equipment (STRIKE)
2021· 13 citedOpen Access
Measurement of the Intracellular Mycobacterium tuberculosis Drug Effect and Prediction of the Clinical Dose–Response Relationship Using Intracellular Pharmacodynamic Modeling (PDi)
Methods in molecular biology·2021
Remdesivir-ivermectin combination displays synergistic interaction with improved <i>in vitro</i> antiviral activity against SARS-CoV-2
2020· 8 citedOpen Access
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?
ACS Infectious Diseases·2020· 50 citedOpen Access
Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis
British Journal of Clinical Pharmacology·2020· 56 citedOpen Access
Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis
Emerging infectious diseases·2020· 76 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Stephen A. Ward(25), Giancarlo A. Biagini(17), Paul M. O’Neill(13), Shaun H. Pennington(10), Andrew Owen(10), Mark Gumbleton(10), W. David Hong(8), Rajith K. R. Rajoli(7), Henry Pertinez(6), Steve P. Rannard(6), Feiko O. ter Kuile(6), Gemma L. Nixon(6), Alison Ardrey(6), Usman Arshad(5), Helen Box(5), Lee Tatham(5), Paul Curley(5), Megan Neary(5), Joanne Sharp(5), Neill J. Liptrott(5)